loading
전일 마감가:
$33.35
열려 있는:
$33.4
하루 거래량:
1.91M
Relative Volume:
0.35
시가총액:
$68.04B
수익:
$39.71B
순이익/손실:
$3.17B
주가수익비율:
9.6796
EPS:
3.4423
순현금흐름:
$6.05B
1주 성능:
-2.97%
1개월 성능:
-12.55%
6개월 성능:
-24.94%
1년 성능:
-5.68%
1일 변동 폭
Value
$33.24
$33.41
1주일 범위
Value
$32.83
$33.79
52주 변동 폭
Value
$32.83
$45.92

글락소스미스클라인 ADR Stock (GSK) Company Profile

Name
명칭
Gsk Plc Adr
Name
전화
-
Name
주소
-
Name
직원
70,200
Name
트위터
@GSK
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
GSK's Discussions on Twitter

GSK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
GSK 33.34 68.04B 39.71B 3.17B 6.05B 3.4423
LLY 745.03 693.54B 40.86B 8.37B -2.28B 5.4193
NVO 102.12 465.74B 39.36B 13.79B 9.83B 2.4077
JNJ 154.48 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 170.66 294.70B 55.53B 5.12B 15.62B 3.65
MRK 98.28 248.54B 63.17B 12.15B 14.84B 1.80

글락소스미스클라인 ADR Stock (GSK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-07-08 다운그레이드 UBS Buy → Neutral
2024-05-30 개시 Goldman Neutral
2024-03-04 업그레이드 Guggenheim Neutral → Buy
2024-02-13 업그레이드 Citigroup Neutral → Buy
2024-01-23 개시 Morgan Stanley Equal-Weight
2024-01-16 재개 UBS Buy
2024-01-03 업그레이드 Jefferies Hold → Buy
2023-07-14 개시 HSBC Securities Reduce
2023-03-17 업그레이드 Deutsche Bank Hold → Buy
2023-02-27 재개 Goldman Buy
2023-01-03 다운그레이드 JP Morgan Neutral → Underweight
2022-12-05 다운그레이드 BofA Securities Neutral → Underperform
2022-11-11 다운그레이드 UBS Neutral → Sell
2022-09-15 업그레이드 Credit Suisse Underperform → Neutral
2022-09-08 다운그레이드 Jefferies Buy → Hold
2022-08-05 재개 Morgan Stanley Equal-Weight
2022-07-21 재개 Citigroup Neutral
2022-02-11 다운그레이드 DZ Bank Buy → Hold
2021-11-05 업그레이드 Barclays Underweight → Equal Weight
2021-06-24 업그레이드 Deutsche Bank Sell → Hold
2021-03-23 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-02-04 다운그레이드 Deutsche Bank Hold → Sell
2021-01-20 다운그레이드 Credit Suisse Neutral → Underperform
2021-01-15 개시 Deutsche Bank Hold
2020-11-02 업그레이드 Liberum Hold → Buy
2020-09-29 개시 Berenberg Buy
2020-02-12 다운그레이드 Shore Capital Hold → Sell
2020-01-16 다운그레이드 Barclays Equal Weight → Underweight
2019-12-02 개시 SVB Leerink Outperform
2019-11-21 업그레이드 UBS Neutral → Buy
2019-10-11 업그레이드 Cantor Fitzgerald Hold → Buy
2019-09-03 재개 Citigroup Neutral
2019-09-03 업그레이드 Societe Generale Sell → Buy
2019-08-13 재개 JP Morgan Neutral
2019-06-17 재개 Morgan Stanley Underweight
2019-03-08 다운그레이드 Shore Capital Buy → Hold
2019-02-22 다운그레이드 UBS Buy → Neutral
2019-01-14 다운그레이드 Exane BNP Paribas Outperform → Neutral
2018-12-11 재개 Jefferies Buy
2018-10-09 개시 Guggenheim Neutral
2018-08-30 다운그레이드 Liberum Buy → Hold
2018-04-04 업그레이드 Exane BNP Paribas Neutral → Outperform
2018-03-22 업그레이드 Morgan Stanley Underweight → Equal-Weight
2018-02-09 업그레이드 Kepler Reduce → Hold
모두보기

글락소스미스클라인 ADR 주식(GSK)의 최신 뉴스

pulisher
Nov 19, 2024

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients - Benzinga

Nov 19, 2024
pulisher
Nov 18, 2024

5 Stocks to Buy While They’re Still Cheap After Earnings - Morningstar

Nov 18, 2024
pulisher
Nov 13, 2024

Diabetes Care Nutrition Market Report 2024 with Forecasts to 2029 - GlobeNewswire Inc.

Nov 13, 2024
pulisher
Nov 12, 2024

The 10 Best Companies to Invest in Now - Morningstar

Nov 12, 2024
pulisher
Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024
pulisher
Nov 04, 2024

The Best Defensive Stocks to Buy - Morningstar

Nov 04, 2024
pulisher
Nov 01, 2024

GSK Plc ADR (NYSE: GSK) Has Outstanding Potential - Stocks Register

Nov 01, 2024
pulisher
Oct 30, 2024

GSK (GSK) Q3 Earnings Surpass Estimates - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About ICICI Bank Ltd. ADR’s (NYSE:IBN) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 25, 2024

GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register

Oct 25, 2024
pulisher
Oct 21, 2024

5 Stocks to Buy if You’re Concerned About US Market Valuations - Morningstar

Oct 21, 2024
pulisher
Oct 18, 2024

21 Best Healthcare Companies to Invest In - Morningstar

Oct 18, 2024
pulisher
Oct 16, 2024

Current share price is - GSK

Oct 16, 2024
pulisher
Oct 15, 2024

D-Wave Quantum Inc (QBTS) rating initates by B. Riley Securities - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

GSK's Studies On Depemokimab For Nasal Polyps Meet Primary Goals - Barchart

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 15, 2024

GSK Plc ADR [GSK] is 5.59% higher this YTD. Is it still time to buy? - The DBT News

Oct 15, 2024
pulisher
Oct 14, 2024

What You Didn’t Know About General Motors Company (NYSE: GM) This Week - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

GSK’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Before You Invest, Make Sure You Check This ADT Inc (NYSE: ADT) Analysis - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

What Are You Thinking About Investing In Medical Properties Trust Inc (NYSE: MPW) Stock? - Stocks Register

Oct 14, 2024
pulisher
Oct 10, 2024

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday - sharewise

Oct 10, 2024
pulisher
Oct 10, 2024

Introducing Our Rant Against GSK Plc ADR - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

GSK Posts New Data From Phase III Study on RSV Vaccine Arexvy - Zacks Investment Research

Oct 10, 2024
pulisher
Oct 09, 2024

Balance Sheet Insights: GSK Plc ADR (GSK)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Pilgrim’s Pride Corp. (PPC) receives an Equal-weight rating from Stephens - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Berenberg upgrades Carnival plc ADR (CUK) stock to a Hold - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

JP Morgan analysts downgrades an Underweight rating for Organon & Co. (OGN) - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

GSK Plc ADR (GSK) gets rating Downgrade from UBS - Knox Daily

Oct 09, 2024
pulisher
Oct 08, 2024

GSK Plc ADR (GSK) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire

Oct 07, 2024
pulisher
Oct 04, 2024

Tenet Healthcare Corp. [THC] stock for 1,879,734 USD was sold by Ramsey R. Scott - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Ratio Analysis: Unpacking GSK Plc ADR (GSK)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 03, 2024
pulisher
Oct 02, 2024

GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

GSK Plc ADR (GSK) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Oct 02, 2024
pulisher
Oct 02, 2024

Cantor Fitzgerald’s latest rating for AMGN stock - Knox Daily

Oct 02, 2024
pulisher
Sep 27, 2024

Nutanix Inc [NTNX] Chief Financial Officer makes an insider sale of 24,316 shares worth 1,430,939. - Knox Daily

Sep 27, 2024
pulisher
Sep 26, 2024

GSK’s Stock Market Adventure: 9.44% YTD Growth Amidst Volatility - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

GSK Shares Experience Decline in Value - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

The Best Healthcare Stocks to Buy - Morningstar

Sep 26, 2024

글락소스미스클라인 ADR (GSK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general BMY
$57.53
price down icon 0.70%
drug_manufacturers_general SNY
$47.64
price down icon 0.22%
drug_manufacturers_general PFE
$24.92
price down icon 0.21%
$286.05
price down icon 0.09%
drug_manufacturers_general NVS
$103.35
price down icon 0.20%
drug_manufacturers_general MRK
$97.70
price up icon 1.40%
자본화:     |  볼륨(24시간):